> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guidance on Lamotrigine BE Recommendations
- URL: https://www.fdaweb.com/draft-guidance-on-lamotrigine-be-recommendations/
- Published: 2016-01-28T12:00:00.000Z
- Updated: 2026-09-15T02:31:41.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134601

*Federal Register* Notice: FDA is making available a revised draft guidance for industry on lamotrigine extended-release tablets entitled *Draft Guidance on Lamotrigine*. The recommendations provide specific guidance on the design of bioequivalence studies to support ANDAs for lamotrigine extended-release tablets. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-01-28/pdf/2016-01683.pdf?ref=fdaweb.com)